Hiltunen, N.; Rintala, J.; Väyrynen, J.P.; Böhm, J.; Karttunen, T.J.; Huhta, H.; Helminen, O.
Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors. Cancers 2022, 14, 2552.
https://doi.org/10.3390/cancers14102552
AMA Style
Hiltunen N, Rintala J, Väyrynen JP, Böhm J, Karttunen TJ, Huhta H, Helminen O.
Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors. Cancers. 2022; 14(10):2552.
https://doi.org/10.3390/cancers14102552
Chicago/Turabian Style
Hiltunen, Niko, Jukka Rintala, Juha P. Väyrynen, Jan Böhm, Tuomo J. Karttunen, Heikki Huhta, and Olli Helminen.
2022. "Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors" Cancers 14, no. 10: 2552.
https://doi.org/10.3390/cancers14102552
APA Style
Hiltunen, N., Rintala, J., Väyrynen, J. P., Böhm, J., Karttunen, T. J., Huhta, H., & Helminen, O.
(2022). Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors. Cancers, 14(10), 2552.
https://doi.org/10.3390/cancers14102552